HCM
CRBP icon

Horrell Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Horrell Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33
Closed -$8K – 200
2020
Q4 		$8K Hold
33
– – ﹤0.01% 150
2020
Q3 		$2K Hold
33
– – ﹤0.01% 169
2020
Q2 		$8K Hold
33
– – ﹤0.01% 134
2020
Q1 		$5K Hold
33
– – ﹤0.01% 146
2019
Q4 		$5K Hold
33
– – ﹤0.01% 158
2019
Q3 		$5K Hold
33
– – ﹤0.01% 168
2019
Q2 		$7K Hold
33
– – ﹤0.01% 151
2019
Q1 		$7K Buy
+33
New +$7.28K ﹤0.01% 148

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Horrell Capital Management's CRBP Position: Q1 2021 in Review

Horrell Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q1 2021, closing a stake of 33 shares — an estimated $8K sold.

Horrell Capital Management first reported a position in CRBP in Q1 2019 and held it in 8 quarters. The position peaked at $8K in Q4 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2021.

  • Horrell Capital Management reported no remaining Corbus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Horrell Capital Management sold 33 Corbus Pharmaceuticals shares in Q1 2021, an estimated $8K.
  • Horrell Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Horrell Capital Management's Corbus Pharmaceuticals position peaked at $8K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2021.

Based on Horrell Capital Management's 13F filing for Q1 2021, filed 5 May 2021.